Paul D. Fey, Ph.D.

Paul D. Fey, Ph.D.
Paul D. Fey, Ph.D.
Phone: 402.559.2122
Email: pfey@unmc.edu

Interests:
Staphylococcal Biology and Pathogenesis
Antibiotic Resistance of Clinical Relevant Pathogens
ProfessorMedical Director, The Nebraska Medical Center Microbiology Section

Research:
Staphylococcus aureus and S. epidermidis are highly significant causes of community and hospital acquired infections. The Fey Laboratory studies multiple aspects of S. epidermidis and S. aureus biology; specifically, the evolution of metabolic pathways that function to facilitate pathogenesis or biofilm formation. We currently have major projects investigating the function of arginine metabolism in both staphylococcal abscess formation and biofilm maturation.  In addition, other projects are ongoing that are studying biofilm adherence factors and proteases that function to regulate biofilm maturation and development. Lastly, investigators in the laboratory are also studying antibiotic resistance in gram-negative and positive bacteria; specifically expanded-spectrum cephalosporin and carbapenem resistance in the Enterobacteriaceae, and daptomycin, vancomycin, and methicillin-resistance in Staphylococcus aureus.??  

Education and Training
B.S., Kansas State University, 1990 (Biology and Microbiology)
Ph.D., Creighton University, 1995 (Medical Microbiology)
Post-Doctoral Fellowship, Medical College of Virginia, 1995-1997

National Activities
Member-American Society for Microbiology
Journal Reviewer-Journal of Infectious Disease
Committee-Nebraska state bill LB1206 Escherichia coli O157;H7 scientific committee

National Speaking Engagements
“Salmonella Typhimurium resistant to third-generation cephalosporins in Nebraska” Status of Molecular Characterization of antimicrobial-resistance in Salmonella.” Centers for Disease Control, Atlanta, GA. Feb 11, 1999.
“b-lactamase analysis of ceftriaxone-resistant Salmonella isolated in United States.” Food Safety Symposium on Antimicrobial Resistance. Centers for Disease Control, Atlanta, GA. September 24, 1999